The BH3 Mimetic, ABT-737, Overcomes Stromal-Mediated Pro-Survival Signals and Synergizes with PHA-767491, a Dual Cdc7 CDK9 Inhibitor, In Acute Myeloid Leukaemia

EVA ERZSEBET SZEGEZDI

The BH3 Mimetic, ABT-737, Overcomes Stromal-Mediated Pro-Survival Signals and Synergizes with PHA-767491, a Dual Cdc7 CDK9 Inhibitor, In Acute Myeloid Leukaemia

EVA ERZSEBET SZEGEZDI

Cellular & Molecular Medicine

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review

Original language	English (Ireland)
Title of host publication	American Society of Hematology Meeting Abstract
Publication status	Published - 1 Nov 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Morrell, R. C.,Szegezdi, E.,Halpin-McCormick, A.,Cawley, K.,Samali, A.,O'Dwyer, M.

Cite this

@inproceedings{a50727f0e4874ef9ad10c954fd618176,

title = "The BH3 Mimetic, ABT-737, Overcomes Stromal-Mediated Pro-Survival Signals and Synergizes with PHA-767491, a Dual Cdc7 CDK9 Inhibitor, In Acute Myeloid Leukaemia",

author = "SZEGEZDI, \{EVA ERZSEBET\}",

year = "2010",

month = nov,

day = "1",

language = "English (Ireland)",

booktitle = "American Society of Hematology Meeting Abstract",

}